Company Profile

Financière de Tubize S.A. is a holding company that owns 36.28% of the listed biopharmacy group UCB.


Source: Cofisem - Last Update: 2026-04-30

Key Executives
Chief Executive Officer Eric Nys
Investor Relations Specialist Eric Nys
Deputy General Manager Anne Keup


Source: Cofisem - Last Update: 2026-04-30

Key Figures
Millenium 2025 2024 2023 2022 2021
Investments revenues 0 13 8
Payroll
Operating income -2,968 -2,236 -2,144 -1,823 381,086
Capital gain from disposals
Income tax
Net income 93,228 90,104 88,151 85,170 380,090
Net income (Group share) 93,228 90,104 88,151 85,170 380,090
Fiscal year end 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards Local GAAP Local GAAP Local GAAP Local GAAP IFRS

Source: Cofisem - Last Update: 2026-04-30

Shareholder information
Other shareholders 46.51 %
Financière Eric Janssen SRL 20.22 %
Daniel Janssen 13.21 %
Altai Invest SA 11.26 %
Barnfin SA 8.8 %


Source: Cofisem - Last Update: 2026-04-30

Address

Financière de Tubize S.A.


Allée de la Recherche 60
BE-1070  Bruxelles
Belgium
http://www.financiere-tubize.be


Source: Cofisem - Last Update: 2026-04-30

Please contact MyQuestion.Italy@euronext.com for Company Profile support.

Quotazioni, Book, Dividendi, Documenti Societari, Corporate Governance, Internal Dealing di Financiere


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.